BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32596362)

  • 21. Axillary evaluation and lymphedema in women with ductal carcinoma in situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Hillyer GC; Chen L; Hershman DL
    Breast Cancer Res Treat; 2016 Jul; 158(2):373-84. PubMed ID: 27365080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival.
    Joslyn SA
    Breast J; 2006; 12(1):20-7. PubMed ID: 16409583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of Surgical Trends for Axillary Lymph Node Management in Patients with Ductal Carcinoma In Situ Using the NSQIP Database: Are We Following National Guidelines?
    Pyfer BJ; Jonczyk M; Jean J; Graham RA; Chen L; Chatterjee A
    Ann Surg Oncol; 2020 Sep; 27(9):3448-3455. PubMed ID: 32232706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of treatment for ductal carcinoma in situ of the breast in Louisiana, 1988-1999.
    Wu X; Chen VW; Ruiz B; Andrews PA; Hsieh MC; Schmidt BA; Correa CN; Fontham ET
    J La State Med Soc; 2003; 155(4):206-13. PubMed ID: 14506828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nipple-sparing mastectomy as treatment for patients with ductal carcinoma in situ: A 10-year follow-up study.
    Lago V; Maisto V; Gimenez-Climent J; Vila J; Vazquez C; Estevan R
    Breast J; 2018 May; 24(3):298-303. PubMed ID: 29139613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study.
    Sagara Y; Mallory MA; Wong S; Aydogan F; DeSantis S; Barry WT; Golshan M
    JAMA Surg; 2015 Aug; 150(8):739-45. PubMed ID: 26039049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
    Shin YD; Lee HM; Choi YJ
    BMC Surg; 2021 Mar; 21(1):159. PubMed ID: 33752671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study.
    Vidali C; Caffo O; Aristei C; Bertoni F; Bonetta A; Guenzi M; Iotti C; Leonardi MC; Mussari S; Neri S; Pietta N
    Radiat Oncol; 2012 Oct; 7():177. PubMed ID: 23098066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in the treatment of ductal carcinoma in situ of the breast.
    Baxter NN; Virnig BA; Durham SB; Tuttle TM
    J Natl Cancer Inst; 2004 Mar; 96(6):443-8. PubMed ID: 15026469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is Sentinel Lymph Node Biopsy Necessary for Ductal Carcinoma In Situ Patients Undergoing Mastectomy?
    Miller-Ocuin JL; Howard-McNatt M; Levine EA; Chiba A
    Am Surg; 2020 Aug; 86(8):955-957. PubMed ID: 32862671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical features and management of women with ductal carcinoma in situ with microinvasion: A retrospective Cohort study.
    Li Y; Zhang S; Wei X; Zhang J
    Int J Surg; 2015 Jul; 19():91-4. PubMed ID: 26013173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ.
    Rakovitch E; Nofech-Mozes S; Hanna W; Narod S; Thiruchelvam D; Saskin R; Spayne J; Taylor C; Paszat L
    Br J Cancer; 2012 Mar; 106(6):1160-5. PubMed ID: 22361634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy.
    Giannakeas V; Sopik V; Narod SA
    JAMA Netw Open; 2018 Aug; 1(4):e181100. PubMed ID: 30646103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association with pregnancy increases the risk of local recurrence but does not impact overall survival in breast cancer: A case-control study of 87 cases.
    Genin AS; De Rycke Y; Stevens D; Donnadieu A; Langer A; Rouzier R; Lerebours F
    Breast; 2016 Dec; 30():222-227. PubMed ID: 26456897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of a Ductal Carcinoma
    Weinmann S; Leo MC; Francisco M; Jenkins CL; Barry T; Leesman G; Linke SP; Whitworth PW; Patel R; Pellicane J; Wärnberg F; Bremer T
    Clin Cancer Res; 2020 Aug; 26(15):4054-4063. PubMed ID: 32341032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is Sentinel Lymph Node Biopsy Indicated at Completion Mastectomy for Ductal Carcinoma In Situ?
    Pilewskie M; Karsten M; Radosa J; Eaton A; King TA
    Ann Surg Oncol; 2016 Jul; 23(7):2229-34. PubMed ID: 26960927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of radiotherapy after breast-conserving surgery in older patients with early breast cancer and breast ductal carcinoma in situ: a meta-analysis.
    Huang XZ; Chen Y; Chen WJ; Zhang X; Wu CC; Zhang CY; Sun SS; Wu J
    Oncotarget; 2017 Apr; 8(17):28215-28225. PubMed ID: 28415667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The management of ductal carcinoma in situ of the breast: a screened population-based analysis.
    Rakovitch E; Pignol JP; Chartier C; Hanna W; Kahn H; Wong J; Mai V; Paszat L
    Breast Cancer Res Treat; 2007 Mar; 101(3):335-47. PubMed ID: 16838110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation.
    Pilewskie M; Olcese C; Eaton A; Patil S; Morris E; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2014 May; 21(5):1552-60. PubMed ID: 24385207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.